Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew F Brown

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Mbio|October 2, 2014
LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogensAndrew P Tomaras, Craig J McPherson, Michael Kuhn, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Nature Chemical Biology|November 17, 2020
Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexesJames Schiemer, Reto Horst, Yilin Meng, et al.
Cancer Research|January 4, 2014
Unbiased compound screening identifies unexpected drug sensitivities and novel treatment options for gastrointestinal stromal tumorsSergei Boichuk, Derek J Lee, Keith R Mehalek, et al.
Journal of Medicinal Chemistry|April 4, 2014
Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteriaJeremy Starr, Matthew F Brown, Lisa Aschenbrenner, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Intramolecular Ring-Opening Decomposition of Aryl AzetidinesGuoyun Bai, Thomas N O'Connell, Michael A Brodney, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Potent small molecule CCR1 antagonistsJohn C Kath, William H Brissette, Matthew F Brown, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptorAmy S Antipas, Laura C Blumberg, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2012
Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agentsLaura A McAllister, Justin I Montgomery, Joseph A Abramite, et al.
The Journal of Biological Chemistry|August 12, 2003
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseasesRonald P Gladue, Laurie A Tylaska, William H Brissette, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Mbio|October 2, 2014
LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogensAndrew P Tomaras, Craig J McPherson, Michael Kuhn, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Nature Chemical Biology|November 17, 2020
Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexesJames Schiemer, Reto Horst, Yilin Meng, et al.
Cancer Research|January 4, 2014
Unbiased compound screening identifies unexpected drug sensitivities and novel treatment options for gastrointestinal stromal tumorsSergei Boichuk, Derek J Lee, Keith R Mehalek, et al.
Journal of Medicinal Chemistry|April 4, 2014
Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteriaJeremy Starr, Matthew F Brown, Lisa Aschenbrenner, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Intramolecular Ring-Opening Decomposition of Aryl AzetidinesGuoyun Bai, Thomas N O'Connell, Michael A Brodney, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Potent small molecule CCR1 antagonistsJohn C Kath, William H Brissette, Matthew F Brown, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptorAmy S Antipas, Laura C Blumberg, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2012
Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agentsLaura A McAllister, Justin I Montgomery, Joseph A Abramite, et al.
The Journal of Biological Chemistry|August 12, 2003
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseasesRonald P Gladue, Laurie A Tylaska, William H Brissette, et al.
Pageof 4